Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its fourth quarter ...
MARC ROSSITER STEPS DOWN AS PRESIDENT, CEO, AND DIRECTOR PREET DHINDSA NAMED INTERIM CEO REAFFIRMS 2025 OUTLOOK AND CONCURRENTLY ANNOUNCES EXPANSION OF DIRECT SHAREHOLDER RETURNS CALGARY, Alberta, Mar ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback